Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.
The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.
The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.
It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.
The trial is due to start next week.
Another power outage has hit three towns on Friday morning, the 30th of May, affecting 120 homes in the Alpes-Maritimes....
Read More
France’s health minister has announced that France will introduce a nationwide ban on smoking in outdoor public areas commonly visited by children, st...
Read More
The Var department has experienced its first "tropical night" of the season, with temperatures not dropping below 25°C at 3 am, particularly in Hyères...
Read More
The Société des Bains de Mer (S.B.M.) has announced solid financial results for the 2024/2025 fiscal year, ending March 31, 2025, with revenue rising ...
Read More
France is set to experience record-breaking heat over the Ascension Day holiday, with tomorrow, Friday, May 30th, expected to be the hottest day of th...
Read More
